Article Text

Download PDFPDF

Correction: Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma

Statistics from Altmetric.com

Goldberg JL, Navid F, Hank JA, et al. Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma. J ImmunoTherapy Cancer 2020;8:e000590. doi: 10.1136/jitc-2020-000590

Since the online publication of this article, the author names ‘Jacquelyn A Hank’ and ‘Stephen D Gillies’ were spelt incorrectly as ‘Jacqueline A Hank’ and ‘Steven D Gillies’. This has now been corrected.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.